%0 Generic %T Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014. %U https://ezaccess.libraries.psu.edu/login?url=https://www.heinonline.org/HOL/Page?handle=hein.cbhear/fdsysacca0001&id=1&size=2&collection=congrec&index=cbhear